monofunctional, being capable of only the adenylation of FMN to form FAD. Studies on bacterial FADS have shown considerable promiscuity in the acceptance of altered FMNs as substrates but absolutely no uptake of different nucleotide triphosphates (e.g. CTP, TTP, etc.). Here we show that bacterial FADS (from C. ammoniagenes, CaFADS) will accept a modified ATP analog, specifically the fluorescent ATP analog aminopurine-2'-deoxyriboside-5'-triphosphate (2ApTP) for the production of dual fluorescent F-2Ap-D. Surprisingly, preliminary experiments indicate the monofunctional hFADS is not similarly promiscuous. These results implicate that this difference in substrate specificity may lead to unique biomarker applications. Understanding these enzymes may also lead to new approaches in nucleoside analog therapeutics. University of Pittsburgh, Pittsburgh, PA, USA, 2 GlaxoSmithKline, King of Prussia, PA, USA. Druggability assessment of a target protein is an important concept in drug discovery. Target flexibility and allostery poses challenges to structure based binding site identification and druggability assessment methods. We developed a simulation-based methodology for comprehensive analysis of the dynamics and binding properties of target proteins (1). Two distinguishing features of the methodology are: (i) simulation of the target in presence of a diversity of probe molecules selected upon analyzing functional groups on approved drugs, (ii) identification of druggable sites and estimation of corresponding maximal affinities based on the geometry and energetics of bound probe clusters. The use of the methodology for a variety of targets such as PTP1B, lymphocyte function-associated antigen 1, and vertebrate kinesin-5 (Eg5) provides shows that the method correctly captures the location and maximal affinities known bindings sites. It also provides insights into the target's structural changes that would accommodate, if not promote and stabilize, drug binding (2). Notably, the ability to identify high affinity spots even in challenging cases such as PTP1B or Eg5 shows promise as a rational tool for assessing the druggability of protein targets, and identifying novel allosteric sites for drug binding. A thorough case study of cytochrome (cyt) c druggability provides further support to the utility of the methodology for prospective targets with limited structural data. We identified the pocket facing heme and accessible in the partially unfolded form of cyt c as a sub-nanomolar druggable site. The first ever pharmacophore model developed for cyt c based on these simulations can distinguish known heme binders and is being advantageously used for discovering new drug-like inhibitors of cyt c. We present a method to design small peptides able of high affinity binding with a preselected target molecule. Our algorithm builds on a combination of molecular dynamics, semi-flexible docking and replica exchange Monte Carlo, and performs simultaneous sampling in sequence and conformational spaces carefully selecting the degree of flexibility in the mutated peptides. The approach is used to design a decapeptide able to bind the anti-HIV drug efavirenz. The calculated binding energy of the designed peptide (approx. À12 kcal/mol) was confirmed experimentally by fluorescence measurements. NMR spectroscopy confirmed the interactions between the peptide and the efavirenz molecule predicted by the algorithm. Here we contribute to the characterization of each CNBD by examining its ability to discriminate between cGMP and a highly similar ligand, cAMP. Relative binding free energies were calculated using molecular dynamic simulations and thermodynamic integration (TI). The contribution of individual residues was assessed by repetition over a series of mutant structures. In some cases, multiple ligand binding conformations (syn vs. anti about the glycosyl bond) were found to meaningfully contribute to the binding free energies. As the barrier to rotation between these conformations prevented adequate sampling on computationally feasible TI timescales, the confine-and-release method was used to account for the contribution of each conformation. This resulted in improved convergence and agreement with experiment. Functional protein-protein interactions are essential for many physiological processes and may play important roles in substrate channeling, coenzyme transfer, and compartmentation in glycolysis. Herein, Brownian dynamics (BD) elucidates the interactions between the glycolytic enzymes glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and lactate dehydrogenase (LDH) and the transfer of the cofactor nicotinamide adenine dinucleotide (NAD) between LDH and GAPDH. BD channeling simulation results strongly depend on choice of reactive atom set. When the reactive atoms set comprise of atoms in the vicinity of the NAD binding site of either enzyme, short NAD trajectories between enzyme subunits occur. If the reactive atoms set were chosen from atoms belonging to NAD binding sites, the efficiency of reaching LDH decreased significantly, and even the shortest trajectories spent time equilibrating with solvent before binding the next active site. Transfer of NAD from GAPDH to LDH is sensitive to overall structure of enzyme-enzyme complex. Small variations in orientation of one enzyme relative to the other cause changes in channeling efficiency. The process of NAD release from GAPDH and LDH binding sites was studied with steered molecular dynamics. The GAPDH/LDH complex with two LDH subunits facing two GAPDH subunits was chosen as initial structure. Six NAD molecules were included -two molecules in GAPDH active subunits and 4 NAD molecules bound to each LDH subunit. External forces were applied to O3 NAD atom of each NAD molecule. MD trajectories (2 ns) with external force (% 1000 pN) were able to pull the NAD out of GAPDH, but not out of LDH. Such strong binding of NAD by LDH is because the nicotinic moiety is buried deep inside LDH subunit globule. Additional studies are needed to confirm the hypothesis that intermolecular contacts soften GAPDH subunit and its affinity to NAD reduces.
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2856-Pos

2857-Pos
2858-Pos Board B13
Enforced Unfolding and Mechanical Properties of the Importin-Beta and Importin-Beta-Binding-Domain Complex Andreas Russek, Helmut Grubmüller. Max Planck Institute for Biophysical Chemistry, Göttingen, Germany. Importin-beta plays an important role in material exchange between the cell nucleus and the cytoplasm. In order to transport large molecules through the nuclear pore complex it has to bind tightly to the importin-beta-binding (IBB) domain of its cargo. To probe the mechanical properties of this binding, enforced unbinding was investigated by single molecule atomic force microscopy (AFM) experiments in which the cargo was pulled out of the complex. To structurally characterize the unfolding pathway, we have performed force probe molecular dynamics (MD) simulations at different constant loading rates on the importin-beta/IBB domain complex. Depending on the applied loading rate, three different unbinding pathways were observed. using time dependent rate theory, these pathways were characterized in terms of the rupture rate, rupture length and the barrier height of the complex, which allow direct comparison with AFM data. We hypothesize that the elastic properties of the involved proteins control binding and unbinding of this complex.
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Investigating the Electrostatic Role of a Critical Arginine for the Catalysis of E. Coli ADP-Glucose Pyrophosphorylase Angela Mahaffey, Saleh Aiyash, Miguel Ballicora. Loyola University-Chicago, Chicago, IL, USA. ADP-glucose pyrophosphorylase (ADP-Glc PPase) is the regulatory enzyme of the pathway for starch synthesis in plants and glycogen in mammals and enteric bacteria. It exists as a 200 kDa homotetramer (a4) in enteric bacteria, and as a heterotetramer (a2b2) in plants. In both in vivo and in vitro the substrates (Glucose 1-Phosphate; Glc-1P and Adenosine 5'-Triphosphate; ATP) are converted into a glucose donor ADP-Glucose and a pyrophosphate (PPi) via the ADP-Glc PPase enzyme. It has been noted that some residues are conserved in homotetrameric bacterial ADP-Glc PPases, but are not in some plant forms. One of them is Arginine-32 (R32) in the Escherichia coli ADP-Glc PPase. To explore the overall role of this residue and evaluate the structural and electrostatic importance of the Arginine's guanidinium group, we replaced it with Lysine (K, -amino group), Alanine (A, -methyl group), Cysteine (C, -sulfide group), Glutamic (E, -carboxylate group), Glutamine (Q, -amido group) and Leucine (L, -hydrophobic side chain) via site directed mutagenesis. We overexpressed the enzymes, purified them to homogeneity, and measured their kinetic properties. The Specific Activity (U/mg) for the mutants were as follows: WT (90.56), R32A (1.65), R32C (0.57), R32E (0.04), R32K (5.81), R32L (0.65) and R32Q (1.37). Currently, the properties of the R32H (Histidine, -imidizoleum ring) mutant are being investigated. Our results clearly indicate that this guanidinium group of the Arginine-32 residue is critical for catalysis. Modeling of the E. coli enzyme suggests that the two (2) nitrogen atoms of the guanidinium group may interact with the b and g phosphates of the ATP, helping in the positioning of the substrates, via electrostatic interactions, and making the PPi product a more stable leaving group.
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Ubiquitin Modulates Tollip Function in the Endocytic Pathway Sharmistha Mitra, Cynthia Alicia Traughber, Stephanie Gomez, Daniel Capelluto. Virginia Tech, Blacksburg, VA, USA. Ubiquitylation is a highly controlled post-translational modification of proteins, in which proteins are conjugated either with monoubiquitin or polyubiquitin chains. Ubiquitin modifications on target proteins are recognized by ubiquitin-binding domains, which are found in several effector proteins. In this study, we describe the function of the Toll-interacting protein (Tollip), which is an effector protein in the innate immune signaling pathway and an adaptor protein for endosomal trafficking. We have previously demonstrated that the central C2 domain of Tollip preferentially interacts with phosphoinositides and that this association is critical for membrane targeting of the protein.
Remarkably, we found that ubiquitin modulates Tollip's lipid binding. We have observed an ubiquitin dose-dependent inhibition of binding of Tollip to phosphoinositides and it does so specifically by blocking Tollip C2 domainphosphoinositide interactions. This led us to hypothesize that the Tollip C2 domain is a novel ubiquitin-binding domain. In addition, we have biophysically characterized the association of the Tollip CUE domain to ubiquitin and identified key interacting residues. The Tollip CUE domain reversibly binds ubiquitin with low micromolar affinity at a site that overlaps with that corresponding to the Tollip C2 domain. We have also found that ubiquitin binding to dimeric Tollip CUE domain induces a drastic conformational change in the protein, leading to the formation of a heterodimeric Tollip CUE-ubiquitin complex. These data suggest that ubiquitin binding to the Tollip C2 and CUE domain and ubiquitin-mediated dissociation of CUE dimer reduces the affinity of the Tollip protein for endosomal phosphoinositides, allowing Tollip cytoplasmic sequestration. Overall, our findings will provide the structural and molecular basis to understand how Tollip, as an endocytic adaptor protein, is modulated by ubiquitin and determines the fate of polyubiquitinated cargo for endosomal degradation. Maintaining membrane proteins at the right place at the right time is crucial to cellular function. To support such organization a broad spectrum of regulating proteins from the cytosol bind, recruit and arrange the membrane proteins into specific structures. PICK1 is an abundant scaffolding protein interacting with more than 30 different receptors, transporters and ion channels, embedded in lipid membranes. PICK1 contains a single N-terminal PDZ domain and forms homodimers via its central membrane bending and curvature sensing N-BAR domain thus forming a functional unit with two PDZ domains. The PICK1 PDZ domain binds many different PDZ peptide ligands such as GluA2, mGluR7 and the dopamine transporter with no apparent conserved binding motif. The wide span of affinities seen for such proteins raises the question of the importance of the affinity for the isolated domain interactions in context of the overall avidity and the functional effects of these interactions. We have established a system based on the previously published supported membrane sheet system to study the binding of PICK1 to a cell membrane expressed ligand to determine the avidity for ''on membrane interactions''. Secondly, we address the functional effects of lowering the affinity of the PDZ domain interactions on the functional effects of PICK1. We demonstrate a dramatic increase in the binding Kd for the oligomeric interaction compared to affinities previously reported in non-native condition binding assays. Furthermore, we show that the interaction is only facilitated by functional PDZ domain. We also observe a significant change in Bmax for lower affinity ligands indicating that the increase of the PDZ affinities might rely on a cooperative binding mechanism of the PICK1 homodimer, which is consistent with results showing that the homodimer binds tighter than the monomer. A common challenge in biophysical studies of membrane proteins is the choice of an adequate model membrane or membrane mimetic. Commonly used mimetics (detergents, liposomes) often suffer from well known limitations (adverse modification of protein structure, inhomogeneous protein distribution, etc.), thus prohibiting extensive studies on membrane proteins. However, the recently developed 'nanodisc' membrane mimetic sytem has helped alleviate some of these shortcomings. Nanodiscs are self assembled proteolipid particles, wherein two copies of an apolipoprotein A-I derived recombinant membrane scaffold protein (MSP) clasp a lipid patch, and seal the hydrophobic edge of the bilayer from water. The incorporation of a membrane protein into the
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